Diabetes and hypertension are the causes of most end-stage renal disea
se (ESRD) in the United States and are also both independent risk fact
ors for cardiovascular disease (CVD). When coexistent, they increase t
he risk twofold to eightfold for CVD morbidity and more than double it
for CVD mortality. If nephropathy is also present, the risk for CVD i
s even greater. A number of clinical studies provide strong evidence o
f the effectiveness of early detection and aggressive treatment of hyp
erglycemia and hypertension in delaying the onset of diabetic nephropa
thy and preventing its progression to ESRD. Such intervention is likel
y to also impact the prevalence of CVD in diabetic individuals. Strate
gies for screening, and treatment of hyperglycemia, hypertension, and
other risk factors to prevent nephropathy and cardiovascular disease a
re discussed.